Evidence map›Paper›PMID 30768591›Full record

ArticlePLoS genetics2019

An African-specific haplotype in MRGPRX4 is associated with menthol cigarette smoking.

Julia Kozlitina, Davide Risso, Katherine Lansu, Reid Hans Johnson Olsen, Eduardo Sainz, Donata Luiselli, Arnab Barik, Carlos Frigerio-Domingues, Luca Pagani, Stephen Wooding and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The structure, function, and pharmacology of MRGPRs.Trends in pharmacological sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Interactions between Chemesthesis and Taste: Role of TRPA1 and TRPV1.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Julia KozlitinaMcDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.ORCID 0000-0001-7720-2290
Davide RissoNational Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.
Katherine LansuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.ORCID 0000-0002-1238-4940
Reid Hans Johnson OlsenDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
Eduardo SainzNational Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.
Donata LuiselliDepartment of Biological, Geological, and Environmental Sciences, University of Bologna, Bologna, Italy.
Arnab BarikNational Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID 0000-0001-6850-0894
Carlos Frigerio-DominguesNational Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.
Luca PaganiEstonian Biocentre, Institute of Genomics, University of Tartu, Estonia.ORCID 0000-0002-6639-524X
Stephen WoodingSchool of Public Health, University of California, Merced, California, United States of America.
Thomas KirchnerSchroeder Institute for Tobacco Research, Washington, District of Columbia, United States of America.
Ray NiauraSchroeder Institute for Tobacco Research, Washington, District of Columbia, United States of America.ORCID 0000-0002-0856-3540
Bryan RothDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
Dennis DraynaNational Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID 0000-0002-1730-4532
National Institutes of Health · USUniversity of North Carolina at Chapel Hill · USEstonian Biocentre · EESouthwestern Medical Center · USUniversity of Bologna · ITUniversity of California, Merced · US

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Genetic Studies of Human Communications DisordersZIADC000046 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI DRAYNA, DENNIS · 2009 to 2019
$21.1M
Scalable technologies for illuminating the druggable GPCR-omeU01MH104974 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROTH, BRYAN L., SHOICHET, BRIAN K · 2014 to 2016
$1.4M
Comparative Effectiveness of Web-based Mobile Support for the DC Tobacco QuitlineRC1DA028710 · NIDA · TRUTH INITIATIVE FOUNDATION · PI KIRCHNER, THOMAS ROBERT · 2009 to 2010
$977k
Regulation of Adult Hippocampal Neurogenesis by Cholecystokinin-Expressing InterneuronsF31NS093917 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI OLSEN, REID HANS JOHNSON · 2015 to 2017
$103k
NCATS NIH HHS UL1 TR001105NIDA NIH HHS RC1 DA028710NIH HHS HHSN263201300011CNIH HHS HHSN263201300011GNIH HHS HHSN263201300011INIMH NIH HHS U01 MH104974NINDS NIH HHS F31 NS093917
6 · The paper itself

Abstract

In the U.S., more than 80% of African-American smokers use mentholated cigarettes, compared to less than 30% of Caucasian smokers. The reasons for these differences are not well understood. To determine if genetic variation contributes to mentholated cigarette smoking, we performed an exome-wide association analysis in a multiethnic population-based sample from Dallas, TX (N = 561). Findings were replicated in an independent cohort of African Americans from Washington, DC (N = 741). We identified a haplotype of MRGPRX4 (composed of rs7102322[G], encoding N245S, and rs61733596[G], T43T), that was associated with a 5-to-8 fold increase in the odds of menthol cigarette smoking. The variants are present solely in persons of African ancestry. Functional studies indicated that the variant G protein-coupled receptor encoded by MRGPRX4 displays reduced agonism in both arrestin-based and G protein-based assays, and alteration of agonism by menthol. These data indicate that genetic variation in MRGPRX4 contributes to inter-individual and inter-ethnic differences in the preference for mentholated cigarettes, and that the existence of genetic factors predisposing vulnerable populations to mentholated cigarette smoking can inform tobacco control and public health policies.

Indexed as

MentholAdultBlack or African AmericanCigarette SmokingCohort StudiesFemaleGenetic VariationHaplotypesHumansMaleMiddle AgedNicotianaReceptors, G-Protein-CoupledSmokingMentholReceptors, G-Protein-Coupled

Identifiers

PMID30768591
PMCPMC6377114
OpenAlexW2914716407

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.